Skip to content

Use of RTMS in anxiety spectrum disorders

A Randomized Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Anxiety Spectrum Disorders - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077628
Enrollment
64
Registered
2024-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: rTMS: A transcranial magnetic stimulation system with a standard 70mm figure-of-eight coil will be utilized for administering rTMS. Frequency will be set at 10 Hz and delivering a total

Sponsors

Tanya Dixit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Principal Diagnosis of Panic disorder, phobic disorder and GAD as per ICD 10 criteria. 2.Moderate to severe anxiety (HAM-A =20) 3.Along with pharmacotherapy (as per IPS guidelines) rTMS / Sham rTMS

Exclusion criteria

Exclusion criteria: Current high suicide risk Comorbid MDD, OCD, psychotic disorders, bipolar spectrum or substance use disorders Neurological disorders like cerebrovascular disease or epilepsy Patient on mood stabiliser,Medical comorbidities or pregnancy and Other contraindications to rTMS like pacemakers or head implants

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is pre-post change in total HAM-A scores and asses efficacy as compared to sham stimulationTimepoint: At 2nd and 4th week

Secondary

MeasureTime frame
Treatment response & remission ratedTimepoint: Treatment response rate (=50% HAM-A reduction), remission rate (HAM-A score =7), changes in WHODAS scores & frequency of adverse events at 2nd week

Countries

India

Contacts

Public ContactTanya Dixit

Kalinga Institute Of Medical Sciences Hospital and College , Bhubaneswar.

r2cdpsy@gmail.com8411044558

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026